278 related articles for article (PubMed ID: 29651748)
1. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
[TBL] [Abstract][Full Text] [Related]
3. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
5. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
[TBL] [Abstract][Full Text] [Related]
6. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
Crome O; Doeppner TR; Schwarting S; Müller B; Bähr M; Weise J
J Neurosci Res; 2007 Jun; 85(8):1734-43. PubMed ID: 17455321
[TBL] [Abstract][Full Text] [Related]
7. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
Garraud M; Khacef K; Vion AC; Leconte C; Yin M; Renard JM; Marchand-Leroux C; Boulanger CM; Margaill I; Beray-Berthat V
J Neurol Sci; 2016 Nov; 370():187-195. PubMed ID: 27772757
[TBL] [Abstract][Full Text] [Related]
9. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
10. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
11. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
Yang Y; Li Q; Yang T; Hussain M; Shuaib A
J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
[TBL] [Abstract][Full Text] [Related]
12. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
13. LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
Arkelius K; Wendt TS; Andersson H; Arnou A; Gottschalk M; Gonzales RJ; Ansar S
Circ Res; 2024 Apr; 134(8):954-969. PubMed ID: 38501247
[TBL] [Abstract][Full Text] [Related]
14. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain.
Bonnin P; Vitalis T; Schwendimann L; Boutigny A; Mohamedi N; Besson VC; Charriaut-Marlangue C
Curr Issues Mol Biol; 2021 Jun; 43(1):301-312. PubMed ID: 34200155
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
You YP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
[TBL] [Abstract][Full Text] [Related]
17. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration.
Gubern-Mérida C; Comajoan P; Huguet G; García-Yebenes I; Lizasoain I; Moro MA; Puig-Parnau I; Sánchez JM; Serena J; Kádár E; Castellanos M
Mol Neurobiol; 2022 Feb; 59(2):1320-1332. PubMed ID: 34984586
[TBL] [Abstract][Full Text] [Related]
18. Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
Lechaftois M; Dreano E; Palmier B; Margaill I; Marchand-Leroux C; Bachelot-Loza C; Lerouet D
PLoS One; 2014; 9(10):e110776. PubMed ID: 25329809
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
Greco R; Tassorelli C; Mangione AS; Levandis G; Certo M; Nappi G; Bagetta G; Blandini F; Amantea D
Eur J Pharmacol; 2014 Dec; 744():91-7. PubMed ID: 25446913
[TBL] [Abstract][Full Text] [Related]
20. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
